London, 30 November 2022 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, is today hosting sell side analysts at its Injectables manufacturing facility in Sintra, Portugal.
30 November 2022
Press Release, Corporate
The visit will primarily provide the opportunity for attendees to tour this state-of-the-art facility which serves as a global hub for the Injectables business, the largest of Hikma’s three divisions. Senior members of the Injectables team will also present on the unique fundamentals of the business, which has a solid track record of revenue growth and strong margins. No new material information will be provided.
The presentation is available on Hikma’s website - click here.